InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Serbousek Jon Carl, Chairman & CEO. Insider active across 1 companies, notably Orthofix Medical Inc.. Cumulatively, 9 disclosures have been logged. Total volume traded: €92k. The latest transaction was filed on 1 April 2022 — Retenue fiscale. Regulator: SEC (Form 4). All data is openly available.
Declarations9 total
€116,3463,899 shares@ €29.84010.019% mcap25.7% of flow
Common Stock
SEC:0001209191-22-023339:0·
081,967 shares0
Common Stock
SEC:0001209191-22-006835·
081,967 shares0
Common Stock
SEC:0001209191-22-006835:0·
€45,9351,670 shares@ €27.5060.0076% mcap27.3% of flow
Common Stock
SEC:0001209191-21-065552·
Ideal exit: 15 Aug 2022 (T+270)
€45,9351,670 shares@ €27.5060.0076% mcap10.2% of flow
Common Stock
SEC:0001209191-21-065552:0·
Ideal exit: 15 Aug 2022 (T+270)
€75,5802,369 shares@ €31.90360.013% mcap45.0% of flow
Common Stock
SEC:0001209191-21-062275·
€75,5802,369 shares@ €31.90360.013% mcap16.7% of flow
Common Stock
SEC:0001209191-21-062275:0·
€46,5291,450 shares@ €32.08930.0077% mcap27.7% of flow
Common Stock
SEC:0001209191-21-050298·
€46,5291,450 shares@ €32.08930.0077% mcap10.3% of flow
Common Stock
SEC:0001209191-21-050298:0·
9 of 9 declarations
About Serbousek Jon Carl
Jon Carl Serbousek is the CEO of Orthofix Medical Inc. He leads the company with a vision focused on innovation in the medical device field. His leadership is crucial for Orthofix's growth, ensuring that the company remains at the forefront of technological advancements.
